Breaking News

ProKidney Purchases Manufacturing Facility in North Carolina

Will support future commercial manufacturing needs for Renal Autologous Cell Therapy.

ProKidney Corp., a late clinical-stage cellular therapeutics company focused on preserving kidney function in patients suffering from chronic kidney disease (CKD), entered into an agreement to purchase a 210,000 square-foot facility and approximately 22 acres of land in Greensboro, N.C. The move is designed to support the company’s future commercial manufacturing needs for REACT, its Renal Autologous Cell Therapy, currently in Phase 3 development for the treatment of diabetic CKD. Under th...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters